Chronos Completes £8m Fund Raising in Over-Subscribed Round

Chronos Therapeutics Ltd completes major fund raise in an over-subscribed round. Funding will support the acceleration of lead compound into neurodegenerative disease. Read the press release.

Contact Us

Want to get in touch? Send us an email.

Not readable? Change text. captcha txt